The challenges of tumor mutational burden as an immunotherapy biomarker
DL Jardim, A Goodman, D de Melo Gagliato… - Cancer cell, 2021 - cell.com
Tumor mutational burden (TMB) reflects cancer mutation quantity. Mutations are processed
to neo-antigens and presented by major histocompatibility complex (MHC) proteins to T …
to neo-antigens and presented by major histocompatibility complex (MHC) proteins to T …
Key changes to the World Health Organization (WHO) classification of female genital tumours introduced in the 5th edition (2020)
WG McCluggage, N Singh, CB Gilks - Histopathology, 2022 - Wiley Online Library
An updated World Health Organization (WHO) classification of female genital tumours was
published in autumn 2020. We discuss the major new additions to and changes from the …
published in autumn 2020. We discuss the major new additions to and changes from the …
SMARCA4: Implications of an Altered Chromatin-Remodeling Gene for Cancer Development and Therapy
K Mardinian, JJ Adashek, GP Botta, S Kato… - Molecular cancer …, 2021 - AACR
The SWI/SNF chromatin remodeling complex, via nucleosome topology modulation,
regulates transcription. The SMARCA4 (BRG1) subunit codes for the ATPase energy engine …
regulates transcription. The SMARCA4 (BRG1) subunit codes for the ATPase energy engine …
Heterogeneity and treatment landscape of ovarian carcinoma
AC Veneziani, E Gonzalez-Ochoa, H Alqaisi… - Nature Reviews …, 2023 - nature.com
Ovarian carcinoma is characterized by heterogeneity at the molecular, cellular and
anatomical levels, both spatially and temporally. This heterogeneity affects response to …
anatomical levels, both spatially and temporally. This heterogeneity affects response to …
[HTML][HTML] SMARCA4: Current status and future perspectives in non-small-cell lung cancer
Y Tian, L Xu, X Li, H Li, M Zhao - Cancer Letters, 2023 - Elsevier
SMARCA4, also known as transcription activator, is an ATP-dependent catalytic subunit of
SWI/SNF (SWItch/Sucrose NonFermentable) chromatin-remodeling complexes that …
SWI/SNF (SWItch/Sucrose NonFermentable) chromatin-remodeling complexes that …
Predisposition to cancer in children and adolescents
CP Kratz, MC Jongmans, H Cavé… - The lancet child & …, 2021 - thelancet.com
Childhood malignancies are rarely related to known environmental exposures, and it has
become increasingly evident that inherited genetic factors play a substantial causal role …
become increasingly evident that inherited genetic factors play a substantial causal role …
Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases
D Holdhof, PD Johann, M Spohn, M Bockmayr… - Acta …, 2021 - Springer
Atypical teratoid/rhabdoid tumors (ATRTs) are very aggressive childhood malignancies of
the central nervous system. The underlying genetic cause are inactivating bi-allelic …
the central nervous system. The underlying genetic cause are inactivating bi-allelic …
The epigenetic hallmarks of cancer
M Esteller, MA Dawson, C Kadoch, FV Rassool… - Cancer …, 2024 - aacrjournals.org
Cancer is a complex disease in which several molecular and cellular pathways converge to
foster the tumoral phenotype. Notably, in the latest iteration of the cancer hallmarks,“ …
foster the tumoral phenotype. Notably, in the latest iteration of the cancer hallmarks,“ …
SWI/SNF complex-deficient undifferentiated carcinoma of the gastrointestinal tract: clinicopathologic study of 30 cases with an emphasis on variable morphology …
B Chang, W Sheng, L Wang, X Zhu, C Tan… - The American Journal …, 2022 - journals.lww.com
Undifferentiated carcinoma of the gastrointestinal tract has variable rhabdoid features.
Expression of switch/sucrose nonfermenting (SWI/SNF) complex subunits is reportedly lost …
Expression of switch/sucrose nonfermenting (SWI/SNF) complex subunits is reportedly lost …
SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+ flux to mitochondria
Inactivating mutations in SMARCA4 and concurrent epigenetic silencing of SMARCA2
characterize subsets of ovarian and lung cancers. Concomitant loss of these key subunits of …
characterize subsets of ovarian and lung cancers. Concomitant loss of these key subunits of …